Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

140,907 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Susceptibility of Mycobacterium tuberculosis to weak acids.
Zhang Y, Zhang H, Sun Z. Zhang Y, et al. Among authors: zhang h. J Antimicrob Chemother. 2003 Jul;52(1):56-60. doi: 10.1093/jac/dkg287. Epub 2003 May 29. J Antimicrob Chemother. 2003. PMID: 12775670
Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
Zhang Y, Permar S, Sun Z. Zhang Y, et al. J Med Microbiol. 2002 Jan;51(1):42-49. doi: 10.1099/0022-1317-51-1-42. J Med Microbiol. 2002. PMID: 11800471
Tuberculosis drug targets.
Zhang Y, Amzel LM. Zhang Y, et al. Curr Drug Targets. 2002 Apr;3(2):131-54. doi: 10.2174/1389450024605391. Curr Drug Targets. 2002. PMID: 11958297 Review.
Escherichia coli genes involved in resistance to pyrazinoic acid, the active component of the tuberculosis drug pyrazinamide.
Schaller A, Guo M, Gisanrin O, Zhang Y. Schaller A, et al. Among authors: zhang y. FEMS Microbiol Lett. 2002 Jun 4;211(2):265-70. doi: 10.1111/j.1574-6968.2002.tb11235.x. FEMS Microbiol Lett. 2002. PMID: 12076823
Salicylate reduces susceptibility of Mycobacterium tuberculosis to multiple antituberculosis drugs.
Schaller A, Sun Z, Yang Y, Somoskovi A, Zhang Y. Schaller A, et al. Among authors: zhang y. Antimicrob Agents Chemother. 2002 Aug;46(8):2636-9. doi: 10.1128/aac.46.8.2636-2639.2002. Antimicrob Agents Chemother. 2002. PMID: 12121945 Free PMC article.
Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.
Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z. Zhang Y, et al. Among authors: zhang h. J Antimicrob Chemother. 2003 Nov;52(5):790-5. doi: 10.1093/jac/dkg446. Epub 2003 Oct 16. J Antimicrob Chemother. 2003. PMID: 14563891
Iron enhances the antituberculous activity of pyrazinamide.
Somoskovi A, Wade MM, Sun Z, Zhang Y. Somoskovi A, et al. Among authors: zhang y. J Antimicrob Chemother. 2004 Feb;53(2):192-6. doi: 10.1093/jac/dkh042. Epub 2004 Jan 16. J Antimicrob Chemother. 2004. PMID: 14729751
Mechanisms of drug resistance in Mycobacterium tuberculosis.
Wade MM, Zhang Y. Wade MM, et al. Among authors: zhang y. Front Biosci. 2004 Jan 1;9:975-94. doi: 10.2741/1289. Front Biosci. 2004. PMID: 14766424 Review.
Persistent and dormant tubercle bacilli and latent tuberculosis.
Zhang Y. Zhang Y. Front Biosci. 2004 May 1;9:1136-56. doi: 10.2741/1291. Front Biosci. 2004. PMID: 14977534 Review.
Accurate mapping of mutations of pyrazinamide-resistant Mycobacterium tuberculosis strains with a scanning-frame oligonucleotide microarray.
Wade MM, Volokhov D, Peredelchuk M, Chizhikov V, Zhang Y. Wade MM, et al. Among authors: zhang y. Diagn Microbiol Infect Dis. 2004 Jun;49(2):89-97. doi: 10.1016/j.diagmicrobio.2004.01.001. Diagn Microbiol Infect Dis. 2004. PMID: 15183857
140,907 results
Jump to page
Feedback